Company Overview of IMI International Medical Innovations, Inc.
IMI International Medical Innovations, LLC, doing business as Procris Pharmaceuticals, is a biotech company involved in discovering, developing, and marketing drugs to treat diabetes pain, cancer and anti-infective and neurological diseases. The company was incorporated in 1991 and is based in Birmingham, Alabama.
2871 Acton Road
Birmingham, AL 35243
Founded in 1991
Key Executives for IMI International Medical Innovations, Inc.
IMI International Medical Innovations, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact IMI International Medical Innovations, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.